Inventor · disambiguated record
Gloria Lin
Also filed as: LIN GLORIA · LIN GLORIA HOI YING
5 granted patents·8 pending applications·0 citations·filing 2013–2023
67Inventor score
Top patents by PatentIndex Score
13 records- 0168US10822388B2Methods and compositions for modulating toso activityUNIV HEALTH NETWORK·Filed 2017·Granted Nov 3, 2020·0 cites·3 claims
- 0266US9321824B2Methods and compositions for modulating Toso activityUNIV HEALTH NETWORK·Filed 2014·Granted Apr 26, 2016·0 cites·6 claims
- 0365US9670265B2Methods and compositions for modulating toso activityUNIV HEALTH NETWORK·Filed 2014·Granted Jun 6, 2017·0 cites·9 claims
- 0465US9624289B2Methods and compositions for modulating Toso activityUNIV HEALTH NETWORK·Filed 2014·Granted Apr 18, 2017·0 cites·5 claims
- 0565US2024018258A1Cd47 blockade therapy with cd38 antibodyPFIZER·Filed 2023·Application pending·0 cites
- 0662US9228006B2Methods and compositions for modulating Toso activityUNIV HEALTH NETWORK·Filed 2013·Granted Jan 5, 2016·0 cites·6 claims
- 0757US2025367255A1Enhancement Of CD47 Blockade Therapy With Anti-VEGF AgentsPFIZER·Filed 2022·Application pending·0 cites
- 0853US2025235504A1Enhancement of cd47 blockade with taxanes for cd47+ cancer therapyPFIZER·Filed 2022·Application pending·0 cites
- 0953US2021040224A1Cd47 blockade therapy with cd38 antibodyTRILLIUM THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1049US2024423983A1Enhancement of cd47 blockade therapy with dhfr inhibitorsPF ARGENTUM IP HOLDINGS LLC·Filed 2022·Application pending·0 cites
- 1144US2021040219A1Improvements in cd47 blockade therapy by egfr antibodyTRILLIUM THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1239US2020157179A1Cd47 blockade therapyTRILLIUM THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1337US2019091290A1Macrophage stimulation in cd47 blockade therapyTRILLIUM THERAPEUTICS INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gloria Lin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →